TITUSVILLE, N.J, JULY 17, 2018 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and
Continue reading »
FDA expands approval of closed-looped insulin delivery system
(HealthDay)—Approval of the MiniMed 670G hybrid closed looped system for diabetes management has been expanded to include individuals aged 7
Continue reading »
FDA Approves Continuous Glucose Monitoring System
THURSDAY, June 28, 2018 — The Eversense Continuous Glucose Monitoring (CGM) system, which has a fully implantable sensor to detect
Continue reading »
Why the FDA Is Warning Parents Against Using Teething Meds
Here’s what to know about the FDA warning. Teething medications may seem an innocuous way to ease an infant’s pain
Continue reading »
Calorie Counts Are Now on Menus Nationwide, But Do They Work?
With the FDA’s new rules, will calorie counts on menus change the way we eat? Chris Hondros | Getty Images
Continue reading »
FDA approves non-opioid treatment for opioid withdrawal
(HealthDay)—Lucemyra (lofexidine hydrochloride) has been approved by the U.S. Food and Drug Administration to treat symptoms of opioid withdrawal. Lucemyra,
Continue reading »
FDA permits marketing of new device for treating GI bleeding
(HealthDay)—The U.S. Food and Drug Administration has approved the new Hemospray device to help control bleeding of the gastrointestinal (GI)
Continue reading »